Evaluation of Serum Ages Levels in Patients With Endometriosis
Study Details
Study Description
Brief Summary
Serum AGES (Advanced Glycation End Products) levels of endometriosis patients are compared with a group of healthy volunteers of the same age.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Serum AGES (Advanced Glycation End Products) levels are compared with 45 endometriosis patients and 45 healthy volunteers of the same age. The energy metabolism of the endometriosis group and its possible relationship with the endometriosis stage will be compared since AGES (Advanced Glycation End Products) gives information about the energy metabolism of the people.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
women with endometriosis It consists of women between the ages of 18-45 who have been diagnosed with endometriosis by surgery or ultrasonography. |
Other: Advanced Glycation End Products (AGEs)
Advanced Glycation End Products (AGEs) releated with energy metabolism, In this study, the possible relationship between the serum levels of Advanced Glycation End Products (AGEs) of endometriosis patients and the disease and its stage is evaluated.
|
control It consists of healthy women between the ages of 18-45 |
Other: Advanced Glycation End Products (AGEs)
Advanced Glycation End Products (AGEs) releated with energy metabolism, In this study, the possible relationship between the serum levels of Advanced Glycation End Products (AGEs) of endometriosis patients and the disease and its stage is evaluated.
|
Outcome Measures
Primary Outcome Measures
- Serum Advanced Glycation End Products (AGEs) levels in women with endometriosis [8 months]
Serum Serum Advanced Glycation End Products (AGEs) levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group
Secondary Outcome Measures
- Comparison of the relationship between serum Serum Advanced Glycation End Products (AGEs) level and endometriosis stage [8 months]
By comparing the relation of serum Advanced Glycation End Products (AGEs) level with the stage of endometriosis, its relation with serum level in patients with advanced and early stage endometriosis will be examined. The possible effect of Advanced Glycation End Products (AGEs) on disease pathogenesis will be examined.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
diagnosed with endometriosis (Surgery or ultrasound)
-
Women without endometriosis
Exclusion Criteria:
- Women without endometriosis women who are only suspected endometriosis
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Pinar Yalcin Bahat | Istanbul | İ̇stanbul | Turkey | 34000 |
Sponsors and Collaborators
- Kanuni Sultan Suleyman Training and Research Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- endo-serum ages levels